Latus Bio, Inc.
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2
$97MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Engineers scalable AAV gene therapies for CNS and rare diseases including Huntington's disease and CLN2